Tharimmune Inc.

NASDAQ: THAR · Real-Time Price · USD
1.33
-0.01 (-0.75%)
At close: Jun 23, 2025, 3:49 PM
1.35
1.50%
After-hours: Jun 23, 2025, 07:59 PM EDT
-0.75%
Bid 1.33
Market Cap 3.54M
Revenue (ttm) n/a
Net Income (ttm) -12.48M
EPS (ttm) -7.85
PE Ratio (ttm) -0.17
Forward PE -1.92
Analyst Buy
Ask 1.45
Volume 13,003
Avg. Volume (20D) 130,561
Open 1.34
Previous Close 1.34
Day's Range 1.30 - 1.36
52-Week Range 0.95 - 6.39
Beta 1.06

About THAR

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol THAR
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for THAR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
6 months ago
+10.84%
Tharimmune shares are trading higher after it anno... Unlock content with Pro Subscription
7 months ago
+68.97%
Tharimmune shares are trading higher after the company announced it received EMA feedback on its TH104 clinical program. The design and main features of the proposed Phase 2 study were deemed acceptable and general guidance was also provided for a future Phase 3 study.